Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMI.L Regulatory News (AMI)

  • There is currently no data for AMI

Marampa Update

25 Nov 2009 07:52

RNS Number : 0455D
African Minerals Ltd
25 November 2009
 



For immediate release

25 November 2009

African Minerals Limited

 ("African Minerals", "AML" or "the Company")

Amendment to Marampa Agreements with Cape Lambert Iron Ore Limited

Highlights:

African Minerals amends agreement with Cape Lambert Iron Ore Limited ("CLIO") re Marampa project

Under the agreement, AML disposes of up to 100% interest in Marampa Iron Ore Limited in return for up to 19.9% of CLIO's issued share capital

Enables AML to focus fully its human and financial resources on its flagship 5.1bn tonne JORC compliant resource at Tonkolili and its associated infrastructure projects

Enables African Minerals to benefit further from additional exposure to CLIO's diverse portfolio of high quality resource assets and consolidates the relationship with CLIO

Allows AML to maintain and benefit from an indirect exposure to Marampa without requiring it to fund the construction and development of the Marampa project

African Minerals Limited (AIM:AMI), the mineral exploration and development company with significant iron ore and base metal interests in Sierra Leone, West Africa, announces that it has amended its agreements with Cape Lambert Iron Ore Limited ("CLIO") (ASX:CFE) in respect of the Marampa iron ore project, previously announced on 1 October 2008 (the "First Marampa Agreement") and 22 January 2009 (the "Second Marampa Agreement").

Under the terms of the amendment agreement ("Amendment Agreement"), AML has agreed to transfer to CLIO a further 28% of the ordinary shares in Marampa Iron Ore Limited ("MIO"), which holds the Marampa exploration licence approximately 150kms northeast of Freetown, in return for 24,569,934 ordinary shares in CLIO (the "Initial Transfer"). This increases CLIO's stake in MIO to 63% and AML's stake in CLIO to 15.2%. 

In addition, under the terms of the Amendment Agreement, AML and CLIO have amended the terms of CLIO's existing option to acquire up to 100% of Marampa. Under the revised option terms, AML has granted CLIO the right to acquire the remaining 37% of MIO's ordinary shares in consideration for issuing to AML 32,592,789 ordinary CLIO shares (the "Second Transfer"). CLIO has, at the same time, elected to exercise that option. The Second Transfer is subject to the approval of CLIO shareholders at a General Meeting which must be convened by CLIO within 45 days from 25 November 2009. If approved, the issue of shares will increase AML's stake in CLIO from 15.2% to 19.9% and CLIO's stake in Marampa to 100%. 

At CLIO's closing share price yesterday of A$0.57 (US$0.53) the value of AML's stake in CLIO after the Initial Transfer is US$44.8m. Upon the Second Transfer, AML's stake in CLIO at the same closing price of A$0.57 (US$0.53) would be valued at US$62.0m.

Background to the First and Second Marampa Agreements

The First Marampa Agreement gave CLIO a 30% interest in Marampa for US$25m (of which only $5m needed to be committed at the time of signing) and 44m CLIO shares with a then market value of $13.2m. Under the First Marampa Agreement AML also granted CLIO an option to acquire all the outstanding shares in MIO for US$200M less the aggregate of US$25M and US$13.2M. 

By the Second Marampa Agreement CLIO increased its shareholding in Marampa from 30% to 35% in return for a further 17m CLIO ordinary shares with a then value of US$3.4m. CLIO retained the option to acquire the 65% balance of MIO's shares for US$200M less the aggregate of US$25M, US$13.2m and US$3.4m. 

Under both the First and Second Marampa Agreements CLIO's option was exercisable entirely at its discretion. In the event that CLIO chose not to exercise the option, the First and Second Marampa Agreements provided for a pro-rata reduction in CLIO's shareholding in MIO by reference to the consideration paid to date and for AML to retain its shareholding in CLIO.

Benefits of the transaction to AML

The Amendment Agreement, assuming the Second Transfer occurs, holds a number of key benefits to African Minerals:

It allows AML to focus its human and financial resources fully on the development of the much larger, 5.1bn tonne resource at Tonkolili and its related infrastructure projects

It allows AML to maintain and benefit from an indirect exposure to Marampa without requiring it to fund the construction and development of the Marampa project

It reduces AML's illiquid, direct interest in Marampa and increases the liquid, indirect interest in the project via CLIO's listed equity.

The increase in AML's shareholding in CLIO to 19.9% increases AML's exposure to the diverse portfolio of high quality resource assets held by CLIO.

It confirms the development of the project will be fully controlled by a highly respected CLIO team who have been on site since October 2008.

As at 31 August 2009, MIO had net assets of US$24.7 million and there was a negligible loss for the year to date associated with the project. AML currently intends to retain the shares in CLIO.

By virtue of its status, before this transaction, as a 35% shareholder of an African Minerals subsidiary, CLIO is deemed to be a related party for the purposes of AIM Rule 13. In accordance with the AIM Rules, the directors consider, having consulted with the Company's nominated adviser, that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned. 

Frank Timis, Executive Chairman of AML commented:

"We are extremely pleased with the terms of the amended agreement. Not only is this a major step forward in consolidating the relationship between CLIO and AML, but it also provides AML with the necessary operational and financial flexibility to intensify our focus on our core project at Tonkolili. CLIO has a strong management team with a proven iron ore industry track record and I am confident in CLIO's ability to realise the full potential of Marampa, demonstrating the attraction of Sierra Leone to mining companies. 

With the increased shareholding in CLIO, AML is well-positioned to benefit from CLIO's strong portfolio of assets whilst remaining fully focused on fast tracking the development of our world-class iron ore project at Tonkolili and the related infrastructure projects."

 Enquiries:

 

African Minerals Limited

Tel: +44 (0) 1481 726833

Frank Timis

Alan Watling

 

 

 

Canaccord Adams Limited

Tel: +44 (0) 20 7050 6500

Mike Jones

Robert Finlay

 

 

 

Mirabaud Securities Limited

Tel: +44 (0) 20 7878 3360

Rory Scott

Pav Sanghara

 

 

 

Pelham Public Relations Limited

Tel: +44 (0) 20 7337 1500

Charles Vivian

Klara Kaczmarek

 

James Macfarlane

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRIIFSDLALEFIA
Date   Source Headline
2nd Apr 20154:59 pmRNSAppointment of Joint Administrators
26th Mar 20154:10 pmRNSAppointment of Administrators
17th Mar 20154:28 pmRNSDirectorate Change
6th Mar 20154:07 pmRNSAdministrators appointment and Nomad resignation
3rd Mar 201511:25 amRNSEnforcement of security by PXF Facility Lenders
27th Feb 20154:51 pmRNSTransfer of PXF and Sierra Leone legal proceedings
16th Feb 20157:02 amRNSDirectorate Change
10th Feb 20157:00 amRNSFinancing Update
2nd Feb 20157:00 amRNSFinancing Update
12th Jan 201511:04 amRNSFinancing Update
29th Dec 20148:06 amRNSResignation of director
12th Dec 201412:23 pmRNSTemporary Marampa Access Agreement and Loan
1st Dec 201411:16 amRNSFinancing and Operations Update
20th Nov 20145:36 pmRNSFinancing Update
20th Nov 20147:59 amRNSSuspension - African Minerals Limited
12th Nov 20144:40 pmRNSSecond Price Monitoring Extn
12th Nov 20144:35 pmRNSPrice Monitoring Extension
12th Nov 20144:04 pmRNSFinancing Update
3rd Nov 20147:00 amRNSCorporate Update
3rd Oct 20148:47 amRNSLitigation Update
30th Sep 201411:25 amRNSInterim Results 2014
29th Sep 20141:34 pmRNSHolding(s) in Company
19th Sep 20147:03 amRNSTonkolili Iron Ore Project funding and operational
11th Sep 20147:00 amRNSNotice of Results
22nd Aug 20141:27 pmRNSChange of Directors
15th Aug 20145:02 pmRNSFunding Update and Management Change
13th Aug 20144:11 pmRNSResult of AGM
13th Aug 20147:00 amRNSHolding(s) in Company
13th Aug 20147:00 amRNSHolding(s) in Company
6th Aug 20147:00 amRNSMarket Update
16th Jul 20147:00 amRNSDirectorate Change
3rd Jul 20147:00 amRNSQ2 2014 and H1 2014 Export Tonnage
3rd Jul 20147:00 amRNSPhase 2 Concentrator Engineering Study Results
2nd Jul 20145:53 pmRNSPosting of 2013 Annual Report
30th Jun 20142:56 pmRNSAnnual Report for the year ended 31 December 2013
27th Jun 20143:02 pmRNSLitigation Outcome and Annual Report posting delay
26th Jun 20147:00 amRNSDe-sliming DSO Fines for enhanced product quality
5th Jun 20147:00 amRNSMedia Reports
21st May 20147:00 amRNSRecord Production and Sales for AML in Q1 2014
13th May 20147:00 amRNSIncrease in DSO Resource
21st Mar 20147:00 amRNSNotice of Results
18th Mar 20148:54 amRNSHolding(s) in Company
17th Feb 20147:00 amRNSAusenco appointed Tonkolili Phase II FEED Engineer
3rd Feb 20147:00 amRNSAdditional Listing on Options and Shares Vesting
31st Jan 20145:10 pmRNSDirector Share Dealings and Share Options
27th Jan 20147:00 amRNSQ4 and FY 2013 Production Report
22nd Jan 20142:56 pmRNSHolding(s) in Company
16th Jan 20147:00 amRNSAdditional Listing on Exercise of Share Options
10th Jan 20147:00 amRNSFY 2013 Production Update
20th Dec 20134:58 pmRNSRelated Party Transactions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.